about
Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.Feasibility and efficacy of accelerated weekly concomitant boost postoperative radiation therapy combined with concomitant chemotherapy in patients with locally advanced head and neck cancer.Fish oil prevents the adrenal activation elicited by mental stress in healthy men.Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysisQuality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients.EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake.Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer riskImpaired insulin response after oral but not intravenous glucose in heart- and liver-transplant recipients.Irinotecan-induced interstitial pneumonia.Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.A metastatic relapse associated with hippocampal dose sparing after whole-brain radiotherapy.Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?Optimization of stereotactic body radiotherapy treatment planning using a multicriteria optimization algorithm.Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer.Abstracts from the 8th Annual Meeting of the Scientific Association of Swiss Radiation Oncology (SASRO).Decrease in hemoglobin levels following surgery influences the outcome in head and neck cancer patients treated with accelerated postoperative radiotherapy.Discrepancies between selected Pareto optimal plans and final deliverable plans in radiotherapy multi-criteria optimization.Extrapleural pneumonectomy with venous confluence resection for stage IVA thymic tumors.Helical tomotherapy for the treatment of anal canal cancer: a dosimetric comparison with 3D conformal radiotherapy.Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study[Working conditions regulated by in-training Swiss physicians: one year of experience][Antiandrogen gynecomastia: an inescapable harm? Radiotherapy: a simple and efficient solution!][Radio-chemotherapy in head and neck cancer (EGFR+)][Manifesto on "Health politics: stop the scuttling!": to (almost) conclude]Personalizing locoregional treatment in the adjuvant setting of early breast cancer on the basis of molecular background: an exciting enigmaToxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)Preoperative hyper-fractionated accelerated radiotherapy (HART) in locally advanced rectal cancer (LARC) immediately followed by surgery. A prospective phase II trialDefinitive organ-sparing treatment of anal canal cancer: can we afford to question it?[PET/CT and radiotherapy: indications and potential applications][Post-operative radiochemotherapy of the head and neck: Towards new standards?]
P50
Q33197476-F87D34D4-0799-453F-A7D9-A362884A146DQ33383657-88E1C704-DDE1-4CC9-B03A-94DF21A7EEDEQ33967674-623C3FE7-DFE7-403F-A9F4-16AEFAD58EA5Q36235528-D0DBE738-B6D5-452B-81F0-79C3DF82087CQ37336206-1DBA2123-E3B1-4A0A-8F95-25C7AD3C6045Q37441925-B624C1B6-F37A-4ABB-A9C1-4BBAF8221126Q37449362-4C3381F2-BE08-49E6-B9E7-D70AC8E86DE5Q38112359-EB8E01DC-3597-4B0C-A228-D4B75BC89391Q38861440-659FB434-687F-468E-929D-133A2B3ED6EEQ40823548-0B7AB371-DBCA-418A-B7F7-D0BC37F0396FQ40927190-24A1F0B4-B78A-4442-91C1-1C1DF6467149Q43566148-60FE3781-5389-4D5F-87DF-AE43A8C18F4BQ44098636-4F68648D-3156-48DB-8999-B46AA827AB98Q44595679-4D925A2C-76FA-44B3-9AB9-9CD4B5A45A50Q44878646-27AF0517-BE65-45BC-8823-36D7445187F9Q45746768-3D4CE1AC-89D4-4D46-B705-D057355ED175Q45915700-F5E98649-F1C8-4FAD-951D-9F18C5DC51A6Q46954439-2866AC32-D414-4709-AFF1-43B586004B31Q48319132-7E8FFB94-75E8-428A-A5A8-E334A840F4A0Q48498412-3EA5CAA1-C41F-47A9-A0FC-6FA1E7D87629Q48860464-73BAF44D-541D-4BEC-BD8B-0D565747ABEFQ50094511-03590B53-64DA-495F-9EE0-C77AA7A0FA66Q50650651-A72A618D-1DE2-4CFE-BE9D-BECD650415C9Q50893967-6D11F876-8B83-458A-874E-1CD92631D6F6Q51307969-06D71F77-8DCC-470E-B3ED-3F82A9066BCDQ51819582-03D26017-3CBD-4208-A541-743C2EB76905Q53085889-0E034111-CC82-48C9-8A7D-47F3A2E756F1Q53242036-6C52BD36-A59C-4220-BCF7-285357FF8875Q53531893-75F7B2E7-4C4B-4153-A646-4BD043939A9FQ64042914-F7F63653-CAFE-4AC1-BFDD-DF3E0E786B32Q79367633-AA2653D4-F934-45DE-BE92-44D138FDAFFEQ79956671-C1FC7FF7-95A0-4904-A786-31B107EC395AQ81316470-6F0647FD-4BDC-4063-B32D-5CF422F190E1Q81692948-C551A19D-E1C3-42EE-B9B2-07ED5EB3BEBCQ82286125-AE8C191E-26C3-40FE-9186-9705277A3BE1Q82640877-9F235356-172C-4428-A5B7-58C860DFE9E6Q82969777-48380B38-CAEC-4DD3-A37E-3656896D4626Q83328051-02CB022D-DFCC-4D5D-A4E2-90D3E6B042D3Q83677250-5662BDD8-EEA4-49A4-9E60-19809817D5CAQ84141208-1E8254F4-BABF-49BC-9746-A5E3448580F8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Oscar Matzinger
@ast
Oscar Matzinger
@en
Oscar Matzinger
@es
Oscar Matzinger
@nl
Oscar Matzinger
@sl
type
label
Oscar Matzinger
@ast
Oscar Matzinger
@en
Oscar Matzinger
@es
Oscar Matzinger
@nl
Oscar Matzinger
@sl
prefLabel
Oscar Matzinger
@ast
Oscar Matzinger
@en
Oscar Matzinger
@es
Oscar Matzinger
@nl
Oscar Matzinger
@sl
P106
P1153
6603119107
P21
P31
P496
0000-0002-5054-1564
P569
2000-01-01T00:00:00Z